Pathway for Differentiation of Human Embryonic Stem Cells to Vascular Cell Components and Their Potential for Vascular Regeneration
- 1 October 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (10), 2127-2134
- https://doi.org/10.1161/atvbaha.107.143149
Abstract
Objective— We demonstrated previously that mouse embryonic stem (ES) cell–derived vascular endothelial growth factor receptor-2 (VEGF- R 2)–positive cells can differentiate into both vascular endothelial cells and mural cells. This time, we investigated kinetics of differentiation of human ES cells to vascular cells and examined their potential as a source for vascular regeneration. Methods and Results— Unlike mouse ES cells, undifferentiated human ES cells already expressed VEGF- R 2, but after differentiation, a VEGF- R 2-positive but tumor rejection antigen 1-60 (TRA1-60)–negative population emerged. These VEGF- R 2-positive but tumor rejection antigen 1-60–negative cells were also positive for platelet-derived growth factor receptor α and β chains and could be effectively differentiated into both VE-cadherin + endothelial cell and α-smooth muscle actin + mural cell. VE-cadherin + cells, which were also CD34 + and VEGF- R 2 + and thought to be endothelial cells in the early differentiation stage, could be expanded while maintaining their maturity. Their transplantation to the hindlimb ischemia model of immunodeficient mice contributed to the construction of new blood vessels and improved blood flow. Conclusions— We could identify the differentiation process from human ES cells to vascular cell components and demonstrate that expansion and transplantation of vascular cells at the appropriate differentiation stage may constitute a novel strategy for vascular regenerative medicine.Keywords
This publication has 17 references indexed in Scilit:
- Adrenomedullin/Cyclic AMP Pathway Induces Notch Activation and Differentiation of Arterial Endothelial Cells From Vascular ProgenitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vesselsBlood, 2006
- Mobilization of Bone Marrow–Derived Cells Enhances the Angiogenic Response to Hypoxia Without Transdifferentiation Into Endothelial CellsCirculation Research, 2005
- Prospective identification of cardiac progenitors by a novel single cell‐based cardiomyocyte inductionThe FASEB Journal, 2005
- A simple and efficient cryopreservation method for primate embryonic stem cellsThe International Journal of Developmental Biology, 2004
- Different Differentiation Kinetics of Vascular Progenitor Cells in Primate and Mouse Embryonic Stem CellsCirculation, 2003
- Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regenerationProceedings of the National Academy of Sciences of the United States of America, 2003
- Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularizationProceedings of the National Academy of Sciences of the United States of America, 2000
- Expressions ofPDGF receptor alpha, c‐KitandFlk1genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cellsDevelopment, Growth & Differentiation, 1997
- The angiogenic potentials of the cephalic mesoderm and the origin of brain and head blood vesselsMechanisms of Development, 1995